| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,478 |
10,846 |
$414K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,936 |
7,039 |
$401K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,758 |
1,522 |
$88K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,430 |
1,221 |
$71K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,262 |
1,089 |
$65K |
| D1208 |
Topical application of fluoride, excluding varnish |
5,961 |
4,968 |
$63K |
| 80061 |
Lipid panel |
5,275 |
4,217 |
$55K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,079 |
5,713 |
$46K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
791 |
704 |
$43K |
| 3008F |
|
5,639 |
4,664 |
$42K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,091 |
3,982 |
$41K |
| 99173 |
|
2,949 |
2,448 |
$37K |
| 87631 |
|
421 |
315 |
$37K |
| 99000 |
|
10,924 |
8,555 |
$31K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,029 |
851 |
$30K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
844 |
715 |
$28K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,204 |
857 |
$26K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,210 |
860 |
$25K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,120 |
804 |
$24K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,258 |
2,578 |
$24K |
| D0140 |
Limited oral evaluation - problem focused |
5,810 |
4,861 |
$24K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
247 |
213 |
$20K |
| 83655 |
|
1,749 |
1,424 |
$17K |
| 82947 |
|
5,289 |
4,220 |
$17K |
| 99188 |
|
1,203 |
952 |
$11K |
| 81003 |
|
6,785 |
5,358 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
471 |
422 |
$10K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
184 |
155 |
$9K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
183 |
140 |
$9K |
| 36416 |
|
4,347 |
3,459 |
$8K |
| 94664 |
|
458 |
382 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
93 |
70 |
$6K |
| 99050 |
|
396 |
352 |
$6K |
| 90656 |
|
1,199 |
1,006 |
$5K |
| 0001A |
|
162 |
154 |
$5K |
| 0002A |
|
117 |
106 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
405 |
337 |
$4K |
| 90686 |
|
411 |
278 |
$3K |
| 90670 |
|
677 |
609 |
$3K |
| 90791 |
Psychiatric diagnostic evaluation |
40 |
25 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
85 |
65 |
$2K |
| 81025 |
|
325 |
210 |
$2K |
| 90698 |
|
317 |
292 |
$1K |
| 90651 |
|
271 |
235 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
109 |
91 |
$1K |
| 90734 |
|
339 |
291 |
$1K |
| 94010 |
|
33 |
30 |
$1K |
| 90621 |
|
212 |
177 |
$1K |
| 90715 |
|
173 |
146 |
$1K |
| 0071A |
|
31 |
25 |
$850.00 |
| 90619 |
|
92 |
75 |
$834.60 |
| 90677 |
|
75 |
56 |
$771.65 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
55 |
49 |
$762.97 |
| 99384 |
|
22 |
12 |
$685.42 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
28 |
12 |
$684.00 |
| 90661 |
|
46 |
30 |
$591.78 |
| 90633 |
|
150 |
132 |
$524.63 |
| 0072A |
|
17 |
13 |
$514.40 |
| 90744 |
|
150 |
121 |
$508.83 |
| 0003A |
|
13 |
13 |
$502.95 |
| 99442 |
|
48 |
29 |
$453.60 |
| 90655 |
|
98 |
89 |
$364.69 |
| 94760 |
|
388 |
327 |
$297.76 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
196 |
106 |
$262.27 |
| J7510 |
Prednisolone oral, per 5 mg |
645 |
356 |
$227.54 |
| 99443 |
|
15 |
15 |
$99.82 |
| 90681 |
|
17 |
15 |
$66.52 |
| 81002 |
|
16 |
16 |
$58.41 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
649 |
357 |
$38.73 |
| 90710 |
|
14 |
12 |
$38.01 |
| 36415 |
Collection of venous blood by venipuncture |
2,905 |
2,385 |
$25.38 |
| 91300 |
|
405 |
335 |
$0.09 |
| 91307 |
|
18 |
13 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
40 |
34 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
469 |
335 |
$0.00 |
| 90461 |
|
161 |
115 |
$0.00 |